IREN – IREN Ltd

IREN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

25.43

Margin Of Safety %

Put/Call OI Ratio

0.69

EPS Next Q Diff

0.47

EPS Last/This Y

0.56

EPS This/Next Y

1.93

Price

18.16

Target Price

58.56

Analyst Recom

1.61

Performance Q

-59.53

Upside

-768.4%

Beta

4.35

Ticker: IREN

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	IREN	30.33	0.80	0.78	3211033
2026-10-15	IREN	30.65	0.79	0.81	3387511
2026-10-16	IREN	27.2	0.77	0.72	3616241
2026-10-19	IREN	27.62	0.80	0.78	3320238
2026-10-20	IREN	26.54	0.78	0.47	3411679
2026-10-21	IREN	27.66	0.77	0.38	3509489
2026-10-22	IREN	25.41	0.77	0.64	3594311
2026-10-23	IREN	24.89	0.74	0.27	3686468
2026-10-26	IREN	25.42	0.75	0.36	3490440
2026-10-27	IREN	27.59	0.73	0.43	3583206
2026-10-28	IREN	29.11	0.73	0.40	3633600
2026-10-29	IREN	25.93	0.72	0.64	3670743
2026-10-30	IREN	23.96	0.72	0.78	3691241
2026-11-02	IREN	22.06	0.73	0.58	3508123
2026-11-03	IREN	24.44	0.73	0.48	3595971
2026-11-04	IREN	21.72	0.71	0.51	3718514
2026-11-05	IREN	17.53	0.71	0.68	3814218
2026-11-06	IREN	21.68	0.69	0.71	3980695
2026-11-09	IREN	21.39	0.71	0.60	3882872
2026-11-10	IREN	19.85	0.70	0.70	4021770
2026-11-11	IREN	20.81	0.71	0.59	4137008
2026-11-12	IREN	19.52	0.70	0.50	4252291
2026-11-13	IREN	18.09	0.69	0.71	4325979
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	IREN	30.48	-100.0	672.6	-3.42
2026-10-15	IREN	30.64	-100.0	672.7	-3.42
2026-10-16	IREN	27.10	-100.0	670.4	-3.42
2026-10-19	IREN	27.71	-100.0	670.8	-3.42
2026-10-20	IREN	27.71	-100.0	670.8	-3.42
2026-10-21	IREN	26.56	-100.0	670.0	-3.42
2026-10-22	IREN	25.60	-100.0	669.4	-3.42
2026-10-23	IREN	24.91	-100.0	670.3	-3.42
2026-10-26	IREN	25.35	-100.0	669.7	-3.42
2026-10-27	IREN	27.48	-100.0	671.1	-3.42
2026-10-28	IREN	29.14	-100.0	672.2	-3.42
2026-10-29	IREN	25.90	-100.0	670.0	-3.42
2026-10-30	IREN	23.90	-100.0	668.7	-3.42
2026-11-02	IREN	22.00	-100.0	667.4	-3.42
2026-11-03	IREN	24.48	-100.0	669.1	-3.42
2026-11-04	IREN	21.72	-100.0	667.2	-3.42
2026-11-05	IREN	17.45	-100.0	664.4	-3.42
2026-11-06	IREN	21.77	-100.0	-	-3.42
2026-11-09	IREN	21.38	-100.0	-	-3.42
2026-11-10	IREN	19.80	-100.0	-	-1.66
2026-11-11	IREN	20.84	-100.0	-	-1.66
2026-11-12	IREN	19.48	-100.0	-	-1.66
2026-11-13	IREN	18.16	-100.0	-	-1.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	IREN	-0.02	22.78	23.65
2026-10-15	IREN	-0.02	22.78	23.65
2026-10-16	IREN	-0.02	22.78	23.65
2026-10-19	IREN	-0.02	18.46	23.65
2026-10-20	IREN	-0.02	18.46	23.03
2026-10-21	IREN	-0.02	18.46	23.00
2026-10-22	IREN	-0.02	18.46	23.00
2026-10-23	IREN	-0.02	18.46	23.00
2026-10-26	IREN	-0.02	15.75	23.00
2026-10-27	IREN	-0.02	15.75	26.65
2026-10-28	IREN	-0.02	15.75	26.65
2026-10-29	IREN	-0.02	15.75	26.65
2026-10-30	IREN	-0.02	15.75	26.65
2026-11-02	IREN	-0.02	15.15	26.65
2026-11-03	IREN	-0.02	15.15	26.65
2026-11-05	IREN	-0.02	15.15	26.65
2026-11-06	IREN	-0.02	15.15	26.65
2026-11-09	IREN	-0.02	6.60	26.65
2026-11-10	IREN	-0.02	6.60	26.65
2026-11-11	IREN	-0.02	6.60	26.67
2026-11-12	IREN	-0.02	6.60	25.43
2026-11-13	IREN	-0.02	6.60	25.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.62

Avg. EPS Est. Current Quarter

-0.71

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

-0.02

Institutional Transactions

6.6

Beta

4.35

Average Sales Estimate Current Quarter

292

Average Sales Estimate Next Quarter

724

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

76.4

Max Drawdown 5-Year %

Target Price

58.56

P/E

Forward P/E

PEG

P/S

11.16

P/B

1.45

P/Free Cash Flow

EPS

-3.72

Average EPS Est. Cur. Y

-1.66

EPS Next Y. (Est.)

0.27

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-195.48

Relative Volume

1.33

Return on Equity vs Sector %

-38.8

Return on Equity vs Industry %

-43.1

EPS 1 7Days Diff

1.8

EPS 1 30Days Diff

1.76

EBIT Estimation

◆ IREN Financial

$18.17

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

0/15

Valuation

12/20

TP/AR

1/10

Options

5/10

RSI

32.7

Range 1M

4.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

12/30

Estimates

1/20

Inst/Vol

7/15

Options

5/10

EPS Yr

6.6%

EPS NY

88.8%

52W%

1.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +29.2% upside

Quality

2/30

Valuation

8/30

Growth

8/25

Stability

4/10

LT Trend

4/5

Upside

+29.2%

Quality

IREN — P/E HistoricalCapital Markets

IREN LIMITED

Sector: Financial Services

Industry: Capital Markets

Employees: 685

IREN Limited operates as a vertically integrated AI cloud services platform in Australia and Canada. It develops, owns, and operates data centers, including the associated land, grid connections, and substations, as well as buildings and cooling. The company also owns and operates compute layers, such as GPUs, CPUs, storage, servers, and networking deployed within that data center infrastructure; and software layers comprising managed services and enterprise support that enables customers to deploy, operate, and manage AI workloads. In addition, it is involved in Bitcoin mining. Further, its division IREN Europe operates a planned AI data center in Badajoz, Spain that deliver approximately 300MW of capacity, including managed services to customers seeking greater choice over where their AI workloads run and how their data and infrastructure are managed in Europe. The company was formerly known as Iris Energy Limited and changed its name to IREN Limited in November 2024. IREN Limited was incorporated in 2018 and is based in Sydney, Australia.

IREN

Latest News

—

Caricamento notizie per IREN…

stock quote shares IREN – IREN Ltd Stock Price stock today

news today IREN – IREN Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch IREN – IREN Ltd yahoo finance google finance

stock history IREN – IREN Ltd invest stock market

stock prices IREN premarket after hours

ticker IREN fair value insiders trading

IMRN – Immuron Limited ADR

IMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.8

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.33

EPS This/Next Y

Price

0.86

Target Price

2.65

Analyst Recom

Performance Q

-17.6

Upside

-596.6%

Beta

1.19

Ticker: IMRN

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	IMRN	1.01	N/A	N/A	0
2026-10-15	IMRN	1.0299	N/A	N/A	0
2026-10-16	IMRN	0.98	N/A	N/A	0
2026-10-19	IMRN	0.9598	N/A	N/A	0
2026-10-20	IMRN	1.01	N/A	N/A	0
2026-10-21	IMRN	0.9885	N/A	N/A	0
2026-10-22	IMRN	0.9443	N/A	N/A	0
2026-10-23	IMRN	0.9601	N/A	N/A	0
2026-10-26	IMRN	0.93	N/A	N/A	0
2026-10-27	IMRN	0.9374	N/A	N/A	0
2026-10-28	IMRN	0.9176	N/A	N/A	0
2026-10-29	IMRN	0.9225	N/A	N/A	0
2026-10-30	IMRN	0.88	N/A	N/A	0
2026-11-02	IMRN	0.8977	N/A	N/A	0
2026-11-03	IMRN	0.8699	N/A	N/A	0
2026-11-04	IMRN	0.8529	N/A	N/A	0
2026-11-05	IMRN	0.8499	N/A	N/A	0
2026-11-06	IMRN	0.8187	N/A	N/A	0
2026-11-09	IMRN	0.8601	N/A	N/A	0
2026-11-10	IMRN	0.9	N/A	N/A	0
2026-11-11	IMRN	0.9338	N/A	N/A	0
2026-11-12	IMRN	0.9699	N/A	N/A	0
2026-11-13	IMRN	0.8785	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	IMRN	1.01	-	-	-0.02
2026-10-15	IMRN	1.03	-	-	-0.02
2026-10-16	IMRN	0.96	-	-	-0.02
2026-10-19	IMRN	0.96	-	-	-0.02
2026-10-20	IMRN	0.96	-	-	-0.02
2026-10-21	IMRN	1.01	-	-	-0.02
2026-10-22	IMRN	0.97	-	-	-0.02
2026-10-23	IMRN	0.95	-	-	-0.02
2026-10-26	IMRN	0.98	-	-	-0.02
2026-10-27	IMRN	0.94	-	-	-0.02
2026-10-28	IMRN	0.92	-	-	-0.02
2026-10-29	IMRN	0.90	-	-	-0.02
2026-10-30	IMRN	0.88	-	-	-0.02
2026-11-02	IMRN	0.90	-	-	-0.02
2026-11-03	IMRN	0.88	-	-	-0.02
2026-11-04	IMRN	0.85	-	-	-0.02
2026-11-05	IMRN	0.85	-	-	-0.02
2026-11-06	IMRN	0.85	-	-	-0.02
2026-11-09	IMRN	0.89	-	-	-0.02
2026-11-10	IMRN	0.90	-	-	-0.02
2026-11-11	IMRN	0.93	-	-	-0.02
2026-11-12	IMRN	0.93	-	-	-0.02
2026-11-13	IMRN	0.86	-	-	-0.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	IMRN	0	10.38	1.90
2026-10-15	IMRN	0	10.38	1.90
2026-10-16	IMRN	0	10.38	1.90
2026-10-19	IMRN	0	10.38	1.90
2026-10-20	IMRN	0	10.38	1.90
2026-10-21	IMRN	0	10.38	1.90
2026-10-22	IMRN	0	10.38	1.90
2026-10-23	IMRN	0	10.38	1.90
2026-10-26	IMRN	0	10.38	1.90
2026-10-27	IMRN	0	10.38	2.04
2026-10-28	IMRN	0	10.38	2.04
2026-10-29	IMRN	0	10.38	2.04
2026-10-30	IMRN	0	10.38	2.04
2026-11-02	IMRN	0	10.38	2.04
2026-11-03	IMRN	0	10.38	2.04
2026-11-05	IMRN	0	10.38	2.04
2026-11-06	IMRN	0	10.38	2.04
2026-11-09	IMRN	0	10.38	2.04
2026-11-10	IMRN	0	10.38	2.04
2026-11-11	IMRN	0	10.38	0.80
2026-11-12	IMRN	0	10.38	0.80
2026-11-13	IMRN	0	10.38	0.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

10.38

Beta

1.19

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.6

Max Drawdown 5-Year %

-84.6

Target Price

2.65

P/E

Forward P/E

PEG

P/S

1.38

P/B

0.93

P/Free Cash Flow

EPS

-0.34

Average EPS Est. Cur. Y

-0.01

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-47.78

Relative Volume

0.01

Return on Equity vs Sector %

-59.4

Return on Equity vs Industry %

-40.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

◆ IMRN Healthcare

$0.89

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

19/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

41.2

Range 1M

43.8%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

18/30

Estimates

1/20

Inst/Vol

5/15

Options

0/10

EPS Yr

98.2%

EPS NY

52W%

17.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +197.8% upside

Quality

6/30

Valuation

16/30

Growth

11/25

Stability

7/10

LT Trend

3/5

Upside

+197.8%

Quality

IMRN — P/E HistoricalBiotechnology

Immuron Limited

Sector: Healthcare

Industry: Biotechnology

Employees: 7

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; ProIBS, an over the counter orally administered product containing the proprietary ingredient AVH200 for the treatment of irritable bowel syndrome; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops IMM-529, which is in Phase II clinical trial for the treatment of Clostridioides difficile infection. In addition, the company offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

IMRN

Latest News

—

Caricamento notizie per IMRN…

stock quote shares IMRN – Immuron Limited ADR Stock Price stock today

news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMRN – Immuron Limited ADR yahoo finance google finance

stock history IMRN – Immuron Limited ADR invest stock market

stock prices IMRN premarket after hours

ticker IMRN fair value insiders trading

IMMP – Immutep Limited ADR

IMMP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.45

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

4.2

EPS This/Next Y

-0.11

Price

3.47

Target Price

19.66

Analyst Recom

Performance Q

-54.98

Upside

-7,421.8%

Beta

2.29

Ticker: IMMP

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	IMMP	3.405	N/A	N/A	0
2026-10-15	IMMP	3.19	N/A	N/A	0
2026-10-16	IMMP	3.19	0.01	999.99	3511
2026-10-19	IMMP	3.185	0.01	999.99	3511
2026-10-20	IMMP	3.18	0.01	999.99	3511
2026-10-21	IMMP	3.255	0.01	999.99	3511
2026-10-22	IMMP	3.21	0.01	999.99	3511
2026-10-23	IMMP	3.2	0.01	999.99	3511
2026-10-26	IMMP	3.09	N/A	N/A	0
2026-10-27	IMMP	3.13	N/A	N/A	0
2026-10-28	IMMP	3.35	N/A	N/A	0
2026-10-29	IMMP	3.35	N/A	N/A	0
2026-10-30	IMMP	3.09	N/A	N/A	0
2026-11-02	IMMP	3.05	N/A	N/A	0
2026-11-03	IMMP	2.99	N/A	N/A	0
2026-11-04	IMMP	2.94	N/A	N/A	0
2026-11-05	IMMP	2.8	N/A	N/A	0
2026-11-06	IMMP	3.49	N/A	N/A	0
2026-11-09	IMMP	3.77	N/A	N/A	0
2026-11-10	IMMP	3.49	N/A	N/A	0
2026-11-11	IMMP	3.59	N/A	N/A	0
2026-11-12	IMMP	3.61	N/A	N/A	0
2026-11-13	IMMP	3.51	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	IMMP	3.36	-	-	-4.00
2026-10-15	IMMP	3.19	-	-	-4.00
2026-10-16	IMMP	3.19	-	-	-4.00
2026-10-19	IMMP	3.16	-	-	-4.00
2026-10-20	IMMP	3.16	-	-	-4.00
2026-10-21	IMMP	3.23	-	-	-4.00
2026-10-22	IMMP	3.20	-	-	-4.00
2026-10-23	IMMP	3.17	-	-	-4.00
2026-10-26	IMMP	3.10	-	-	-3.12
2026-10-27	IMMP	3.14	-	-	-3.12
2026-10-28	IMMP	3.31	-	-	-3.12
2026-10-29	IMMP	3.34	-	-	-3.12
2026-10-30	IMMP	3.09	-	-	-3.12
2026-11-02	IMMP	2.99	-	-	-3.12
2026-11-03	IMMP	2.97	-	-	-3.12
2026-11-04	IMMP	2.90	-	-	-3.12
2026-11-05	IMMP	2.70	-	-	-3.12
2026-11-06	IMMP	3.26	-	-	-3.12
2026-11-09	IMMP	3.71	-	-	-3.12
2026-11-10	IMMP	3.52	-	-	-3.12
2026-11-11	IMMP	3.58	-	-	-3.12
2026-11-12	IMMP	3.65	-	-	-3.12
2026-11-13	IMMP	3.47	-	-	-3.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	IMMP	0.00	0	0.64
2026-10-15	IMMP	0.00	0	0.64
2026-10-16	IMMP	0.00	0	0.64
2026-10-19	IMMP	0.00	0	0.64
2026-10-20	IMMP	0.00	0	0.64
2026-10-21	IMMP	0.00	0	0.64
2026-10-22	IMMP	0.00	0	0.64
2026-10-23	IMMP	0.00	0	0.64
2026-10-26	IMMP	0.00	0	0.64
2026-10-27	IMMP	0.00	0	0.46
2026-10-28	IMMP	0.00	0	0.46
2026-10-29	IMMP	0.00	0	0.46
2026-10-30	IMMP	0.00	0	0.46
2026-11-02	IMMP	0.00	-96.53	0.46
2026-11-03	IMMP	0.00	-96.53	0.46
2026-11-05	IMMP	0.00	-96.53	0.46
2026-11-06	IMMP	0.00	-96.53	0.46
2026-11-09	IMMP	0.00	-95.77	0.46
2026-11-10	IMMP	0.00	-95.77	0.46
2026-11-11	IMMP	0.00	-95.77	0.45
2026-11-12	IMMP	0.00	-95.77	0.45
2026-11-13	IMMP	0.00	-95.77	0.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-95.77

Beta

2.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-96.9

Target Price

19.66

P/E

Forward P/E

PEG

P/S

2.56

P/B

0.6

P/Free Cash Flow

EPS

-7.28

Average EPS Est. Cur. Y

-3.12

EPS Next Y. (Est.)

-3.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-534.13

Relative Volume

0.69

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

0.9

EPS 1 30Days Diff

0.88

EBIT Estimation

◆ IMMP Healthcare

$3.48

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

13/25

Volume

9/15

Valuation

12/20

TP/AR

5/10

Options

0/10

RSI

46.7

Range 1M

62.1%

Sup Dist

4.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

18/30

Estimates

6/20

Inst/Vol

0/15

Options

0/10

EPS Yr

74.6%

EPS NY

17%

52W%

1.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +464.9% upside

Quality

6/30

Valuation

16/30

Growth

15/25

Stability

6/10

LT Trend

2/5

Upside

+464.9%

Quality

IMMP — P/E HistoricalBiotechnology

Immutep Limited

Sector: Healthcare

Industry: Biotechnology

Employees:

Immutep Limited, a clinical-stage biotechnology company, develops lymphocyte activation gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases in Australia. The company's lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on the LAG-3 immune control mechanism for the treatment of cancer. Its product pipeline also includes AIPAC-003, which has completed an integrated Phase II/III clinical trial for the treatment of metastatic breast cancer; TACTI-003, which has completed a Phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (1L HNSCC); an investigator-initiated Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in patients with early-stage HR+/HER2-negative breast cancer; and EFTISARC-NEO, which is in a Phase II clinical trial for the treatment of soft tissue sarcoma. In addition, the company develops INSIGHT-003, which is in a Phase I trial for 1L non squamous non-small cell lung cancer (NSCLC); EOC 202, which has completed a Phase I trial for metastatic breast cancer; IMP761, an agonist LAG-3 antibody in a Phase I trial; IMP731, a LAG-3 depleting antibody that has completed a Phase II trial for ulcerative colitis and a Phase I trial for psoriasis; and ieramilimab/LAG525/IMP701, which are anti-LAG-3 antagonist antibodies. It has collaborations with Merck & Co., Inc., Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, the Maria Sklodowska-Curie National Research Institute of Oncology, EOC Pharma, Dr Reddy's Laboratories, Monash University, and George Washington University. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.

IMMP

Latest News

—

Caricamento notizie per IMMP…

stock quote shares IMMP – Immutep Limited ADR Stock Price stock today

news today IMMP – Immutep Limited ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch IMMP – Immutep Limited ADR yahoo finance google finance

stock history IMMP – Immutep Limited ADR invest stock market

stock prices IMMP premarket after hours

ticker IMMP fair value insiders trading

GENE – Genetic Technologies Ltd. ADR

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=GENE #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

GENE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.76

Target Price

6.87

Analyst Recom

Performance Q

-14.99

Upside

N/A

Beta

1.11

Ticker: GENE

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	GENE	0.765	N/A	N/A	0
2026-10-15	GENE	0.765	N/A	N/A	0
2026-10-16	GENE	0.765	N/A	N/A	0
2026-10-19	GENE	0.765	N/A	N/A	0
2026-10-20	GENE	0.765	N/A	N/A	0
2026-10-21	GENE	0.765	N/A	N/A	0
2026-10-22	GENE	0.765	N/A	N/A	0
2026-10-23	GENE	0.765	N/A	N/A	0
2026-10-26	GENE	0.765	N/A	N/A	0
2026-10-27	GENE	0.765	N/A	N/A	0
2026-10-28	GENE	0.765	N/A	N/A	0
2026-10-29	GENE	0.765	N/A	N/A	0
2026-10-30	GENE	0.765	N/A	N/A	0
2026-11-02	GENE	0.765	N/A	N/A	0
2026-11-03	GENE	0.765	N/A	N/A	0
2026-11-04	GENE	0.765	N/A	N/A	0
2026-11-05	GENE	0.765	N/A	N/A	0
2026-11-06	GENE	0.765	N/A	N/A	0
2026-11-09	GENE	0.765	N/A	N/A	0
2026-11-10	GENE	0.765	N/A	N/A	0
2026-11-11	GENE	0.765	N/A	N/A	0
2026-11-12	GENE	0.765	N/A	N/A	0
2026-11-13	GENE	0.765	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=GENE 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-97.7

Target Price

6.87

P/E

Forward P/E

PEG

P/S

1.24

P/B

2.89

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-156.76

Relative Volume

Return on Equity vs Sector %

-680.2

Return on Equity vs Industry %

-667.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=GENE 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=GENE 589 450 ]

No data found for GENE

GENE — P/E HistoricalDiagnostics & Research

[News_GENE _Stock]

stock quote shares GENE – Genetic Technologies Ltd. ADR Stock Price stock today

news today GENE – Genetic Technologies Ltd. ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch GENE – Genetic Technologies Ltd. ADR yahoo finance google finance

stock history GENE – Genetic Technologies Ltd. ADR invest stock market

stock prices GENE premarket after hours

ticker GENE fair value insiders trading

WDS – Woodside Energy Group Ltd

WDS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.17

Margin Of Safety %

-6

Put/Call OI Ratio

0.11

EPS Next Q Diff

EPS Last/This Y

0.46

EPS This/Next Y

0.04

Price

21.07

Target Price

23.62

Analyst Recom

2.59

Performance Q

-10.74

Upside

167.3%

Beta

0.44

Ticker: WDS

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	WDS	23.05	0.08	0.00	10599
2026-10-15	WDS	23.27	0.08	0.01	10599
2026-10-16	WDS	23.65	0.08	0.00	10602
2026-10-19	WDS	23.73	0.10	0.00	5316
2026-10-20	WDS	23.61	0.10	0.00	5385
2026-10-21	WDS	23.62	0.10	0.00	5392
2026-10-22	WDS	22.89	0.10	0.02	5452
2026-10-23	WDS	23.66	0.10	0.07	5471
2026-10-26	WDS	23.34	0.10	0.00	5483
2026-10-27	WDS	23.16	0.10	0.00	5591
2026-10-28	WDS	22.86	0.10	0.02	5629
2026-10-29	WDS	23.18	0.10	0.02	5729
2026-10-30	WDS	23.55	0.10	0.63	5754
2026-11-02	WDS	22.53	0.10	0.45	5788
2026-11-03	WDS	22.37	0.10	0.19	5840
2026-11-04	WDS	21.53	0.10	0.01	5983
2026-11-05	WDS	21.44	0.11	0.00	5890
2026-11-06	WDS	20.77	0.10	0.13	5945
2026-11-09	WDS	21	0.10	0.60	5957
2026-11-10	WDS	21.07	0.11	0.00	5971
2026-11-11	WDS	21.22	0.11	0.15	5970
2026-11-12	WDS	21.24	0.11	0.00	5973
2026-11-13	WDS	21.07	0.11	1.00	5987
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	WDS	23.06	-	-	2.00
2026-10-15	WDS	23.27	-	-	2.00
2026-10-16	WDS	23.65	-	-	2.00
2026-10-19	WDS	23.73	-	-	2.00
2026-10-20	WDS	23.73	-	-	2.00
2026-10-21	WDS	23.61	-	-	2.00
2026-10-22	WDS	22.91	-	-	2.00
2026-10-23	WDS	23.65	-	-	2.00
2026-10-26	WDS	23.34	-	-	1.89
2026-10-27	WDS	23.17	-	-	1.89
2026-10-28	WDS	22.86	-	-	1.89
2026-10-29	WDS	23.18	-	-	1.89
2026-10-30	WDS	23.55	-	-	1.89
2026-11-02	WDS	22.53	-	-	1.89
2026-11-04	WDS	21.52	-	-	1.89
2026-11-05	WDS	21.43	-	-	1.89
2026-11-06	WDS	21.03	-	-	1.89
2026-11-09	WDS	20.98	-	-	1.89
2026-11-10	WDS	21.07	-	-	1.89
2026-11-11	WDS	21.22	-	-	1.89
2026-11-12	WDS	21.24	-	-	1.89
2026-11-13	WDS	21.07	-	-	1.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	WDS	0	0.73	0.17
2026-10-15	WDS	0	0.73	0.17
2026-10-16	WDS	0	0.73	0.17
2026-10-19	WDS	0	0.80	0.17
2026-10-20	WDS	0	0.80	0.17
2026-10-21	WDS	0	0.80	0.17
2026-10-22	WDS	0	0.80	0.17
2026-10-23	WDS	0	0.80	0.17
2026-10-26	WDS	0	0.71	0.17
2026-10-27	WDS	0	0.71	0.18
2026-10-28	WDS	0	0.71	0.18
2026-10-29	WDS	0	0.71	0.18
2026-10-30	WDS	0	0.71	0.18
2026-11-02	WDS	0	1.01	0.18
2026-11-03	WDS	0	1.01	0.18
2026-11-05	WDS	0	1.01	0.18
2026-11-06	WDS	0	1.01	0.18
2026-11-09	WDS	0	0.96	0.18
2026-11-10	WDS	0	0.96	0.18
2026-11-11	WDS	0	0.96	0.17
2026-11-12	WDS	0	0.96	0.17
2026-11-13	WDS	0	0.96	0.17
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.96

Beta

0.44

Average Sales Estimate Current Quarter

3613

Average Sales Estimate Next Quarter

3704

Fair Value

19.75

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

21.8

Max Drawdown 5-Year %

-48.8

Target Price

23.62

P/E

13.1

Forward P/E

9.95

PEG

3.12

P/S

2.88

P/B

1.11

P/Free Cash Flow

EPS

1.61

Average EPS Est. Cur. Y

1.89

EPS Next Y. (Est.)

1.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

22.23

Relative Volume

0.9

Return on Equity vs Sector %

-7.4

Return on Equity vs Industry %

-9.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.11

EBIT Estimation

◆ WDS Energy

$21.08

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

21/25

Volume

7/15

Valuation

11/20

TP/AR

0/10

Options

5/10

RSI

35.2

Range 1M

11.7%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

17/30

Estimates

5/20

Inst/Vol

5/15

Options

6/10

EPS Yr

27.1%

EPS NY

16.5%

52W%

61.2%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +110.7% upside

Quality

9/30

Valuation

16/30

Growth

15/25

Stability

4/10

LT Trend

3/5

Upside

+110.7%

Quality

MoS

-6%

WDS — P/E HistoricalOil & Gas E&P

Woodside Energy Group Limited

Sector: Energy

Industry: Oil & Gas E&P

Employees: 4693

Woodside Energy Group Ltd engages in the exploration, evaluation, development, production, marketing, and sale of hydrocarbons in the Asia Pacific, Africa, the Americas, and the Europe. It produces liquefied natural gas, pipeline gas, crude oil and condensate, and natural gas liquids. The company holds interests in the Pluto LNG, North West Shelf, Wheatstone and Julimar-Brunello, Bass Strait, Ngujima-Yin FPSO, Okha FPSO, Pyrenees FPSO, Macedon, Shenzi, Mad dog, Greater Angostura, as well as Scarborough, Sangomar, Trion, Calypso, Browse, Liard, Ruby, Sangomar, Atlantis, Woodside Solar opportunity, and Sunrise and Troubadour. It is also involved in the development of new energy products and lower-carbon services. The company was formerly known as Woodside Petroleum Ltd and changed its name to Woodside Energy Group Ltd in May 2022. Woodside Energy Group Ltd was founded in 1954 and is headquartered in Perth, Australia.

WDS

Latest News

—

Caricamento notizie per WDS…

stock quote shares WDS – Woodside Energy Group Ltd Stock Price stock today

news today WDS – Woodside Energy Group Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch WDS – Woodside Energy Group Ltd yahoo finance google finance

stock history WDS – Woodside Energy Group Ltd invest stock market

stock prices WDS premarket after hours

ticker WDS fair value insiders trading

BHP – BHP Group Limited

BHP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.76

Margin Of Safety %

-11

Put/Call OI Ratio

1.79

EPS Next Q Diff

EPS Last/This Y

0.82

EPS This/Next Y

0.09

Price

79.47

Target Price

Analyst Recom

Performance Q

-10.05

Upside

-36.7%

Beta

0.88

Ticker: BHP

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	BHP	83.27	1.43	1.97	152107
2026-10-15	BHP	82.89	1.43	6.75	153722
2026-10-16	BHP	83.28	1.44	2.35	154860
2026-10-19	BHP	83.21	1.46	0.29	142131
2026-10-20	BHP	81.88	1.41	0.78	145050
2026-10-21	BHP	80.81	1.41	0.48	144958
2026-10-22	BHP	77.58	1.41	2.75	145404
2026-10-23	BHP	77.88	1.40	1.06	145384
2026-10-26	BHP	79.12	1.40	39.57	145653
2026-10-27	BHP	82.6	1.81	1.59	174629
2026-10-28	BHP	82.23	1.82	1.48	175719
2026-10-29	BHP	81.84	1.82	1.45	175702
2026-10-30	BHP	79.18	1.83	0.59	176338
2026-11-02	BHP	80.08	1.81	1.30	176903
2026-11-03	BHP	78.1	1.80	4.18	177584
2026-11-04	BHP	80.14	1.80	0.90	177576
2026-11-05	BHP	78.57	1.79	1.68	178160
2026-11-06	BHP	79.93	1.79	1.40	178354
2026-11-09	BHP	82.86	1.78	0.96	179683
2026-11-10	BHP	81.14	1.78	1.00	180073
2026-11-11	BHP	82.04	1.78	1.14	180248
2026-11-12	BHP	80.5	1.79	0.81	180203
2026-11-13	BHP	79.47	1.79	0.99	180543
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	BHP	83.26	-	-135.5	4.71
2026-10-15	BHP	82.91	-	-232.1	4.71
2026-10-16	BHP	83.26	-	425.7	4.68
2026-10-19	BHP	83.22	-	303.4	4.68
2026-10-20	BHP	83.22	-	303.4	4.68
2026-10-21	BHP	81.88	-	-45.5	4.68
2026-10-22	BHP	77.57	-	-593.6	4.69
2026-10-23	BHP	77.86	-	408.2	4.69
2026-10-26	BHP	79.11	-	698.5	4.69
2026-10-27	BHP	82.62	-	1682.2	4.69
2026-10-28	BHP	82.25	-	537.8	4.69
2026-10-29	BHP	81.84	-	530.9	4.69
2026-10-30	BHP	79.16	-	-127.5	4.69
2026-11-02	BHP	80.07	-	901.8	4.69
2026-11-03	BHP	78.11	-	-162.5	4.69
2026-11-04	BHP	80.13	-	1231.6	4.69
2026-11-05	BHP	78.57	-	166.7	4.69
2026-11-06	BHP	79.87	-	979.5	4.69
2026-11-09	BHP	82.86	-	1490.4	4.69
2026-11-10	BHP	81.11	-	110.5	4.69
2026-11-11	BHP	82.04	-	874.0	4.69
2026-11-12	BHP	80.54	-	184.7	4.69
2026-11-13	BHP	79.47	-	315.7	4.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	BHP	0	0.90	0.83
2026-10-15	BHP	0	0.90	0.83
2026-10-16	BHP	0	0.90	0.83
2026-10-19	BHP	0	3.19	0.83
2026-10-20	BHP	0	3.19	0.83
2026-10-21	BHP	0	3.19	0.83
2026-10-22	BHP	0	3.19	0.83
2026-10-23	BHP	0	3.19	0.83
2026-10-26	BHP	0	1.62	0.83
2026-10-27	BHP	0	1.62	0.76
2026-10-28	BHP	0	1.62	0.76
2026-10-29	BHP	0	1.62	0.76
2026-10-30	BHP	0	1.62	0.76
2026-11-02	BHP	0	1.70	0.76
2026-11-03	BHP	0	1.70	0.76
2026-11-05	BHP	0	1.70	0.76
2026-11-06	BHP	0	1.70	0.76
2026-11-09	BHP	0	1.63	0.76
2026-11-10	BHP	0	1.63	0.76
2026-11-11	BHP	0	1.63	0.76
2026-11-12	BHP	0	1.63	0.76
2026-11-13	BHP	0	1.63	0.76
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.63

Beta

0.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

70.97

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.5

Max Drawdown 5-Year %

-37.2

Target Price

P/E

20.52

Forward P/E

16.14

PEG

P/S

3.43

P/B

3.97

P/Free Cash Flow

16.88

EPS

3.87

Average EPS Est. Cur. Y

4.69

EPS Next Y. (Est.)

4.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.73

Relative Volume

0.62

Return on Equity vs Sector %

2.7

Return on Equity vs Industry %

2.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.36

EBIT Estimation

315.7

◆ BHP Basic Materials

$79.49

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

11/25

Volume

9/15

Valuation

7/20

TP/AR

2/10

Options

1/10

RSI

43.9

Range 1M

31.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

3/30

Estimates

6/20

Inst/Vol

4/15

Options

3/10

EPS Yr

-4.9%

EPS NY

-0.4%

52W%

58.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -14.5% upside

Quality

22/30

Valuation

0/30

Growth

3/25

Stability

4/10

LT Trend

3/5

Upside

-14.5%

Quality

MoS

-11%

BHP — P/E HistoricalOther Industrial Metals & Mining

BHP Group Limited

Sector: Basic Materials

Industry: Other Industrial Metals & Mining

Employees: 38833

BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, and South America. The company operates through three segments: Copper, Iron Ore, and Coal. It explores for copper, iron, steelmaking coal, energy coal, nickel, potash, cobalt, sulphide, ammonium sulphate, silver, gold, molybdenum, uranium, and zinc deposits. The company is also involved in the services, marketing, trading, and finance businesses; potash, nickel, and copper development; mining, smelting, refining of nickel; and provision of towing, freight, administrative, and marketing support and other services. BHP Group Limited was founded in 1851 and is headquartered in Melbourne, Australia.

BHP

Latest News

—

Caricamento notizie per BHP…

stock quote shares BHP – BHP Group Limited Stock Price stock today

news today BHP – BHP Group Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch BHP – BHP Group Limited yahoo finance google finance

stock history BHP – BHP Group Limited invest stock market

stock prices BHP premarket after hours

ticker BHP fair value insiders trading

No more stocks to show

IREN – IREN Ltd

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IREN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

IMRN – Immuron Limited ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IMRN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y